Consistently, our in vivo studies showed that inhibition of IL-1β level with caspase-1 inhibitor dramatically reduced MPO activity in the liver and ameliorated liver fibrosis in BDL mouse model, suggesting an important role of IL-1β in triggering tissue inflammation and fibrosis during cholestasis. This evidence concerns the gene IL1B and cholestasis.